-46.9%
ASTS vs GSK
+9.8%
-56.7%
-77.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.5% | +0.5% | -6.0% | -5.5% |
| 7D | +0.8% | +1.1% | -0.3% | +0.8% |
| 30D | -22.6% | +6.3% | -29.0% | -22.9% |
| 3M | -54.4% | +1.8% | -56.2% | -54.2% |
| 6M | -56.4% | +1.7% | -58.1% | -56.2% |
| YTD | -55.1% | +6.5% | -61.7% | -54.6% |
| 1Y | -46.9% | +9.5% | -56.4% | -48.4% |
| All | -46.9% | +9.8% | -56.7% | -48.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling